|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 7 of 28 found articles
| Title: |
Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial |
| Author: |
Walter, Thomas Lievre, Astrid Coriat, Romain Malka, David Elhajbi, Farid Di Fiore, Fréderic Hentic, Olivia Smith, Denis Hautefeuille, Vincent Roquin, Guillaume Perrier, Marine Dahan, Laetitia Granger, Victoire Sobhani, Iradj Mineur, Laurent Niccoli, Patricia Assenat, Eric Scoazec, Jean-Yves Le Malicot, Karine Lepage, Côme Lombard-Bohas, Catherine |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 24 () nr. 3 pages 297-306 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 7 of 28 found articles
| << previous | next >> |